Nevro (NYSE:NVRO) announced today that it received FDA approval for an AI-powered, personalized pain management platform for spinal cord stimulation.
Neurable announced today that it launched the MW75 Neuro smart headphones integrated with its brain-computer interface (BCI) technology.
The new device offers unified visualisation with true 4K Imaging and 4K narrow band imaging as well as blue light observation.
Nico sells devices for navigating through the brain, visualizing the organ, removing tumors and clots and collecting tissue.
Alesi Surgical has received FDA 510(k) clearance of its Ultravision2 IonPencil for cutting and coagulating soft tissue in open surgery while managing surgical smoke.
Helen Foster, 58, of Hackenthorpe, is one of the first patients in South Yorkshire to benefit from a treatment to remove blood clots from the blood vessels in her lungs.
Research from the University of Michigan suggests that one day a phone app could be able to detect the development of hepatic encephalopathy in patients just by listening to them speak.
Leveraging rapid technological advances for human health is a global trend, driving the rise of biomedical engineering research.
Neuralink announced on social media that it received FDA breakthrough device designation for its vision-restoring Blindsight implant.
GE HealthCare (Nasdaq: GEHC)+
announced today that the FDA has cleared its new imaging tool to assess people with potential Alzheimer’s disease.